Prevention of Acute Kidney Injury in Patients With NSTEMI
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled, multi-center, phase 2 clinical study in
patients with NSTEMI undergoing urgent coronary angiography. Approximately 220 patients with
CKD and acute NSTEMI, who are scheduled for an urgent coronary angiography (within 72 hours
after admission and/or diagnosis of NSTEMI).